• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (24)
    • Recruitment planning for clinical trials with a vulnerable perinatal adolescent population using the Clinical Trials Transformative Initiative framework and principles of partner and community engagement.
    • Role of protein kinase C epsilon (PKCvarepsilon) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shell.
    • Phosphorylation of transcription factors.
    • Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    • Platelets acquire a secretion defect after high-dose chemotherapy.
    • See All 24 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Platelets acquire a secretion defect after high-dose chemotherapy.

Platelets acquire a secretion defect after high-dose chemotherapy. Cancer. 1990 Apr 15; 65(8):1711-6.

View in: PubMed

subject areas
  • Adenosine Triphosphate
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols
  • Blood Platelet Disorders
  • Blood Platelets
  • Bone Marrow Transplantation
  • Breast Neoplasms
  • Carmustine
  • Cisplatin
  • Cyclophosphamide
  • Female
  • Hemorrhage
  • Humans
  • Male
  • Melanoma
  • Melphalan
  • Middle Aged
  • Myocarditis
  • Platelet Aggregation

authors with profiles
  • Charles S Greenberg